ALPINE, UT, May 25 /PRNewswire-FirstCall/ - Clifton Mining Company
(Clifton) (OTC:CFTN) announces that American Biotech Labs (ABL), a private
company in which Clifton holds a 25% interest, has recently signed an MOU with
General Resonance(TM), LLC, to form a Joint Venture.
General Resonance, a cutting-edge science and technology company located
in Maryland, scrutinized the science and technologies of ABL, along with
Professor Rustum Roy, who concurrently holds appointments with The
Pennsylvania State University, Arizona State University and The University
of Arizona. Professor Roy helped found the number one ranked materials science
laboratory in the world, the Materials Research Institute at The Pennsylvania
State University. Professor Roy is regarded as one of the top material
scientists in the world and sits on several countries' national academies of
In discussions regarding ABL products, General Resonance (GR) was
impressed with the scientific engineering aspects, and the very high quality
of ABL products; ABL was equally impressed with GR's fundamental understanding
of the engineering, physics, and medical phenomena associated with ABL's
products, as well as GR's business and marketing background. As a result, the
companies have agreed to form a joint venture.
This ABL-GR Joint Venture will broaden and accelerate the development and
applications of ABL's engineered, silver nano-particles. The combination of
GR science and technology with ABL's existing products and technologies
creates a new scientific and commercial synergy that promises to generate even
greater opportunities for the future.
Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward
looking are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Editors and investors are cautioned
that forward looking statements invoke risk and uncertainties that may affect
the company's business prospects and performance.
SOURCE Clifton Mining Company